Bolt Biotherapeutics, Inc. (BOLT) earnings
BOLT earnings moved a median of -2.06% by the close. Quarterly and annual BOLT reports and results, each read against the price at its own news timestamp. Back to the BOLT overview →
21 measured BOLT earnings events.
Where these BOLT earnings landedvs 19 measured BOLT earnings reactions
| Middle 50% of BOLT earnings reactions | -4.11% to +0.48% |
|---|---|
| Median reaction (to close) | -2.06% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 BOLT earnings events with a measured close landed between -4.11% and +0.48%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -7.27% | -13.53% | |
| Form 10-Q Bolt Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -7.27% | -13.53% | |
| Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.00% | +3.43% | |
| Form 10-Q Bolt Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.43% | |
| Form 10-K Bolt Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.74% | |
| Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -2.16% | — | |
| Form 10-Q Bolt Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.16% | — | |
| Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | — | -3.01% | |
| Form 10-Q Bolt Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -3.01% | |
| Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -4.11% | |
| Form 10-Q Bolt Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.11% | |
| Form 10-K Bolt Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.06% | |
| Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +1.60% | -2.06% | |
| Form 10-Q Bolt Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.60% | -2.06% | |
| Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -1.07% | -1.07% | |
| Form 10-Q Bolt Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.07% | -1.07% | |
| Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team | Press release | -9.10% | -18.63% | |
| Form 10-Q Bolt Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -9.10% | -18.63% | |
| Form 10-K Bolt Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.62% | +3.45% | |
| Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +3.07% | +2.02% | |
| Form 10-Q Bolt Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.07% | +2.02% |
Keep exploring
More BOLT: analyst actions → · SEC filings → · BOLT overview →